Cellectar Biosciences, Inc. (CLRB)
3.23
+0.27
(+9.12%)
USD |
NASDAQ |
Mar 12, 16:00
3.25
+0.02
(+0.62%)
After-Hours: 20:00
Cellectar Biosciences Shareholders Equity (Quarterly) : 9.919M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| EyePoint Plc | 306.11M |
| Ocugen, Inc. | -12.17M |
| ACADIA Pharmaceuticals, Inc. | 1.227B |
| Alnylam Pharmaceuticals, Inc. | 789.18M |
| Savara, Inc. | 94.39M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 14.98M |
| Total Liabilities (Quarterly) | 5.059M |
| Debt to Equity Ratio | 0.0413 |
| Current Ratio | 2.956 |
| Net Debt Paydown Yield | 0.16% |